Browse the full record of transactions filed by Sherman Matthew L, EVP et Directeur Médical. Insider active across 1 companies, notably Deciphera Pharmaceuticals, Inc.. In total, 9 reports have been published. Total volume traded: €186k. The latest transaction was filed on 16 June 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Matthew L. Sherman serves as EVP & Chief Medical Officer at Deciphera Pharmaceuticals, Inc. He is responsible for leading the company's medical and research initiatives. Matthew plays a key role in developing innovative treatments and improving patient outcomes. His medical expertise is essential for Deciphera's mission.